1 enrolling by invitation. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Enrolling by invitation 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Nasus Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FMXIN002 in Patients at Risk of Anaphylaxis Epinephrine 4mg nasal powder spray, Adrenalin 0.5mg Injectable Product - Anaphylaxis Food | Phase 2 / Phase 3 | Enrolling by invitation | Nasus Pharma | 30 | 2025-06-12 | 2025-07-01 |
Epinephrine (1) · Injections (1)
Israel (1)